MacroGenics Inc.

09/11/2020 | Press release | Archived content

ESMO 2020 MGD019 (PD 1 x CTLA 4) Phase 1 Dose Escalation Oral Presentation

MacroGenics Inc. published this content on September 11, 2020, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 23, 2025 at 17:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]